Protocol summary

Study aim
The effect of melatonin on coronary perfusion after PPCI in patients with myocardial infarction
Design
Double blinded, controlled randomized trial
Settings and conduct
Patients with STEMI PPCI candidate referred to Modarres Hospital are divided into two groups. Patients in the case group will receive 3 mg of melatonin before PPCI and control group will receive placebo before PPCI without melatonin. The patient is not aware of the type of drug received.Doctors who perform PPCI and those who complete patient information are not informed about the type of medication being taken.
Participants/Inclusion and exclusion criteria
Inclusion criteria: being at least 18 years old; PPCI for the first 6 hours; STEMI evidence in patient electrocardiogram; blockage of one of the major coronary arteries; verbal Desire and Written Patient Satisfaction. Exclusion criteria: ESRD; history of autoimmune diseases; patient with severe illness with short prognosis; atrial fibrilation before or after PPCI; pregnancy or breast feeding.
Intervention groups
Case groupe will receive 3 mg of melatonin before PPCI and the control group will receive PPCI without melatonin
Main outcome variables
Changes in coronary artery perfusion

General information

Reason for update
Acronym
MCP
IRCT registration information
IRCT registration number: IRCT20191214045726N1
Registration date: 2020-01-15, 1398/10/25
Registration timing: prospective

Last update: 2020-01-15, 1398/10/25
Update count: 0
Registration date
2020-01-15, 1398/10/25
Registrant information
Name
zahra alipour
Name of organization / entity
Country
Iran (Islamic Republic of)
Phone
+98 21 2208 3106
Email address
z_alipour@yahoo.com
Recruitment status
Recruitment complete
Funding source
Expected recruitment start date
2020-01-21, 1398/11/01
Expected recruitment end date
2021-01-20, 1399/11/01
Actual recruitment start date
empty
Actual recruitment end date
empty
Trial completion date
empty
Scientific title
Effect of Melatonin on Coronary perfusion after primary percutaneous coronary intervention
Public title
Effect of Melatonin on Coronary perfusion after primary percutaneous coronary intervention
Purpose
Treatment
Inclusion/Exclusion criteria
Inclusion criteria:
Acute Myocardial infarction Age older than 18 years old PPCI for the first 6 hours STEMI evidence in patient electrocardiogram Blockage of one of the major coronary arteries Verbal desire and written patient satisfaction to participate in the study
Exclusion criteria:
Chronic renal failure A history of autoimmune disease Atrial fibrilation Pregnancy or breast feeding
Age
From 18 years old
Gender
Both
Phase
2-3
Groups that have been masked
No information
Sample size
Target sample size: 64
Randomization (investigator's opinion)
Randomized
Randomization description
Eligible patients randomly assigned in 1:1 rathio and the computer is classified into two groups of case and control
Blinding (investigator's opinion)
Not blinded
Blinding description
Placebo
Not used
Assignment
Parallel
Other design features

Secondary Ids

empty

Ethics committees

1

Ethics committee
Name of ethics committee
Ethics Committee of Biomedical Research Vice Chancellor for Research of Shahid Beheshti University o
Street address
7th Floor, Bldg No.2 SBUMS, Arabi Ave, Daneshjoo Blvd, Velenjak, Tehran, Iran.
City
Tehran
Province
Tehran
Postal code
19839-63113
Approval date
2019-11-03, 1398/08/12
Ethics committee reference number
IR.SBMU.RETECH.REC.1398.371

Health conditions studied

1

Description of health condition studied
Myocardial infarction
ICD-10 code
I21.3
ICD-10 code description
ST elevation (STEMI) myocardial infarction of unspecified site

Primary outcomes

1

Description
Changes in coronary artery perfusion
Timepoint
Determination of coronary perfusion before PPCI and within 40 days after PPCI
Method of measurement
Angiography and echocardiography

Secondary outcomes

empty

Intervention groups

1

Description
Intervention group: 3 mg melatonin given to patients with myocardial infarction before PPCI instead of melatonin.
Category
Treatment - Drugs

2

Description
Control group: patients with myocardial infarction who receive placebo
Category
Placebo

Recruitment centers

1

Recruitment center
Name of recruitment center
Modarres hospital
Full name of responsible person
Zahra Alipur
Street address
7th Floor, Bldg No.2 SBUMS, Arabi Ave, Daneshjoo Blvd, Velenjak, Tehran, Iran.
City
Tehran
Province
Tehran
Postal code
19839-63113
Phone
+98 21 2207 4087
Email
z_alipour@yahoo.com
Web page address
https://modarres.sbmu.ac.ir/

Sponsors / Funding sources

1

Sponsor
Name of organization / entity
Shahid Beheshti University of Medical Sciences
Full name of responsible person
Afshin Zarghi
Street address
7th Floor, Bldg No.2 SBUMS, Arabi Ave, Daneshjoo Blvd, Velenjak, Tehran, Iran.
City
Tehran
Province
Tehran
Postal code
19839-63113
Phone
+98 21 23871
Email
zarghi@sbmu.ac.ir
Web page address
http://cvrc.sbmu.ac.ir/
Grant name
Clinical Research Development Center, Shahid Modarres Educational hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Grant code / Reference number
Is the source of funding the same sponsor organization/entity?
Yes
Title of funding source
Shahid Beheshti University of Medical Sciences
Proportion provided by this source
100
Public or private sector
Public
Domestic or foreign origin
Domestic
Category of foreign source of funding
empty
Country of origin
Type of organization providing the funding
Academic

Person responsible for general inquiries

Contact
Name of organization / entity
Shahid Beheshti University of Medical Sciences
Full name of responsible person
Vahid Eslami
Position
Assistant professor
Latest degree
Subspecialist
Other areas of specialty/work
Cardiology
Street address
7th Floor, Bldg No.2 SBUMS, Arabi Ave, Daneshjoo Blvd, Velenjak, Tehran, Iran.
City
Tehran
Province
Tehran
Postal code
19839-63113
Phone
+98 21 4087 2207
Email
veslami3525@yahoo.com
Web page address
https://modarres.sbmu.ac.ir/

Person responsible for scientific inquiries

Contact
Name of organization / entity
Shahid Beheshti University of Medical Sciences
Full name of responsible person
Vahid Eslami
Position
Assistant professor
Latest degree
Subspecialist
Other areas of specialty/work
Cardiology
Street address
7th Floor, Bldg No.2 SBUMS, Arabi Ave, Daneshjoo Blvd, Velenjak, Tehran, Iran.
City
Tehran
Province
Tehran
Postal code
19839-63113
Phone
+98 21 4087 2207
Email
veslami3525@yahoo.com

Person responsible for updating data

Contact
Name of organization / entity
Shahid Beheshti University of Medical Sciences
Full name of responsible person
Zahra Alipour
Position
rezident
Latest degree
Specialist
Other areas of specialty/work
Cardiology
Street address
7th Floor, Bldg No.2 SBUMS, Arabi Ave, Daneshjoo Blvd, Velenjak, Tehran, Iran.
City
Tehran
Province
Tehran
Postal code
19839-63113
Phone
+98 21 4087 2207
Email
z_alipour@yahoo.com
Web page address
https://modarres.sbmu.ac.ir/

Sharing plan

Deidentified Individual Participant Data Set (IPD)
No - There is not a plan to make this available
Justification/reason for indecision/not sharing IPD
No more information
Study Protocol
No - There is not a plan to make this available
Statistical Analysis Plan
Not applicable
Informed Consent Form
No - There is not a plan to make this available
Clinical Study Report
No - There is not a plan to make this available
Analytic Code
Not applicable
Data Dictionary
Not applicable
Loading...